OncoMatch/Clinical Trials/NCT07820644
A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)
Official title: A Single-center, Open-label, Single-arm, Observational Cohort Study on Early Diagnosis and Risk Prediction of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Based on a Digital Management Platform
Is NCT07820644 recruiting? Yes, currently enrolling (Oct 2026).
Evaluating the effectiveness of standardized HCC risk stratification management in improving early diagnosis rates in patients with chronic liver disease
Check if I qualifyExtracted eligibility criteria
Cancer type
Hepatocellular Carcinoma
Disease stage
Metastatic disease required
Liver Cancer (Primary and Metastatic)
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07820644 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages